Sunday, October 30, 2016: 8:00 AM-9:15 AM
Room: 383-385
Co-organized with the IDSA Clinical Affairs Committee and SHEA Guidelines Committee
Learning Objectives:
At the conclusion of this session, participants will be able to:
- describe the process and evaluation performed for this new guideline update
- examine the current approaches to managing adult patients with HAP/VAP
- discuss the recommendations proposed by the updated IDSA/ATS Guidelines on the management of adults with HAP/VAP
Target Audience: Academicians, Clinicians, Fellows, Hospital administrators, Hospital epidemiologists, Infection preventionists, Infectious diseases physicians, Members-in-training, Pharmacists, Researchers, Scientists
Tracks: Adult ID
Moderators:
Andre C. Kalil, MD, MPH, FIDSA, University of Nebraska Medical Center
and
Mark Metersky, MD, University of Connecticut School of Medicine
Presentations:
CME Credits: Maximum of 1.25 hours of
AMA PRA Category 1 Credit™
ACPE Credits: ACPE 1.25 knowledge-based contact hours .125 of pharmacy CE
ACPE Number: 0221-9999-16-303-L01-P
Disclosures:
A. C. Kalil,
None
M. Metersky,
Bayer:
Consultant
and
Grant Investigator
,
Consulting fee
and
Grant recipient